Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenya Tang

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Cold Spring Harbor Molecular Case Studies|June 12, 2021
Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>-<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapyAndrés E Quesada, Rajyalakshmi Luthra, Elias Jabbour, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
An Incidental Finding of Gain of a Diminished Chromosome 12 Centromere in an Individual with Lymphocytosis: A Case Report and Clinical Implications in Cytogenetic TestingChangqing Xia, Jeffrey J Cannatella, Scott C Smith, et al.
Cancer Genetics|May 22, 2019
Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrationsZhenya Tang, Guilin Tang, Shimin Hu, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Data in Brief|June 14, 2019
Data on <i>MECOM</i> rearrangement-driven chromosomal aberrations in myeloid malignanciesZhenya Tang, Guilin Tang, Shimin Hu, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Haematologica|December 1, 2022
<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphomaLianqun Qiu, Guilin Tang, Shaoying Li, et al.
Cancer Cytopathology|September 25, 2023
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridizationJohn Diks, Zhenya Tang, Mehmet Altan, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Cold Spring Harbor Molecular Case Studies|June 12, 2021
Incidental identification of inv(16)(p13.1q22)/<i>CBFB</i>-<i>MYH11</i> variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapyAndrés E Quesada, Rajyalakshmi Luthra, Elias Jabbour, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
An Incidental Finding of Gain of a Diminished Chromosome 12 Centromere in an Individual with Lymphocytosis: A Case Report and Clinical Implications in Cytogenetic TestingChangqing Xia, Jeffrey J Cannatella, Scott C Smith, et al.
Cancer Genetics|May 22, 2019
Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrationsZhenya Tang, Guilin Tang, Shimin Hu, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Data in Brief|June 14, 2019
Data on <i>MECOM</i> rearrangement-driven chromosomal aberrations in myeloid malignanciesZhenya Tang, Guilin Tang, Shimin Hu, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Haematologica|December 1, 2022
<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphomaLianqun Qiu, Guilin Tang, Shaoying Li, et al.
Cancer Cytopathology|September 25, 2023
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridizationJohn Diks, Zhenya Tang, Mehmet Altan, et al.
Pageof 14